Similar articles for PMID: 30796165

Year	Number of Results
1999	1
2002	2
2003	2
2004	1
2007	1
2008	1
2009	2
2010	1
2012	1
2013	3
2014	1
2015	3
2016	3
2017	12
2018	11
2019	17
2020	17
2021	16
2022	11
2023	13
2024	2

1

Early Phase I Study of a ^99mTc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer.

Xing Y, Chand G, Liu C, Cook GJR, O'Doherty J, Zhao L, Wong NCL, Meszaros LK, Ting HH, Zhao J. Xing Y, et al. J Nucl Med. 2019 Sep;60(9):1213-1220. doi: 10.2967/jnumed.118.224170. Epub 2019 Feb 22. J Nucl Med. 2019. PMID: 30796165 Free PMC article. Clinical Trial.

2

Noninvasive Imaging of Tumor PD-L1 Expression Using [^99mTc]Tc-Labeled KN035 with SPECT/CT.

Zhang Y, Ding Y, Li N, Wang S, Zhou S, Li R, Yang H, Li W, Qu J. Zhang Y, et al. Mol Pharm. 2023 Jan 2;20(1):690-700. doi: 10.1021/acs.molpharmaceut.2c00874. Epub 2022 Dec 21. Mol Pharm. 2023. PMID: 36541699

3

Inter-rater and intra-rater agreement of [^99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer.

Hughes DJ, Chand G, Johnson J, Bailey D, Adamson K, Goh V, Cook GJR. Hughes DJ, et al. EJNMMI Res. 2023 May 31;13(1):51. doi: 10.1186/s13550-023-01002-4. EJNMMI Res. 2023. PMID: 37256434 Free PMC article.

4

Inter- and intraobserver agreement of the quantitative assessment of [^99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.

Hughes DJ, Chand G, Goh V, Cook GJR. Hughes DJ, et al. EJNMMI Res. 2020 Dec 1;10(1):145. doi: 10.1186/s13550-020-00734-x. EJNMMI Res. 2020. PMID: 33259032 Free PMC article. Retracted.

5

PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer.

Smit J, Borm FJ, Niemeijer AN, Huisman MC, Hoekstra OS, Boellaard R, Oprea-Lager DE, Vugts DJ, van Dongen GAMS, de Wit-van der Veen BJ, Thunnissen E, Smit EF, de Langen AJ. Smit J, et al. J Nucl Med. 2022 May;63(5):686-693. doi: 10.2967/jnumed.121.262473. Epub 2021 Aug 12. J Nucl Med. 2022. PMID: 34385342 Free article.

6

First-in-Humans Evaluation of a PD-L1-Binding Peptide PET Radiotracer in Non-Small Cell Lung Cancer Patients.

Zhou X, Jiang J, Yang X, Liu T, Ding J, Nimmagadda S, Pomper MG, Zhu H, Zhao J, Yang Z, Li N. Zhou X, et al. J Nucl Med. 2022 Apr;63(4):536-542. doi: 10.2967/jnumed.121.262045. Epub 2021 Jul 29. J Nucl Med. 2022. PMID: 34326125 Free PMC article.

7

Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8⁺ T cell and iNKT cell activating mRNA vaccine.

Ertveldt T, Meulewaeter S, De Vlaeminck Y, Olarte O, Broos K, Van Calenbergh S, Bourgeois S, Deprez J, Heremans Y, Goyvaerts C, Staels W, De Smedt S, Dewitte H, Devoogdt N, Keyaerts M, Verbeke R, Barbé K, Lentacker I, Breckpot K. Ertveldt T, et al. Theranostics. 2023 Oct 9;13(15):5483-5500. doi: 10.7150/thno.85106. eCollection 2023. Theranostics. 2023. PMID: 37908728 Free PMC article.

8

Preclinical evaluation and pilot clinical study of [⁶⁸Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging.

Ma X, Zhou X, Hu B, Li X, Yao M, Li L, Qin X, Li D, Yao Y, Hou X, Liu S, Chen Y, Wang Z, Zhou W, Li N, Zhu H, Jia B, Yang Z. Ma X, et al. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3838-3850. doi: 10.1007/s00259-023-06373-3. Epub 2023 Aug 9. Eur J Nucl Med Mol Imaging. 2023. PMID: 37555904

9

Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non-Small Cell Lung Cancer.

Niemeijer AN, Oprea-Lager DE, Huisman MC, Hoekstra OS, Boellaard R, de Wit-van der Veen BJ, Bahce I, Vugts DJ, van Dongen GAMS, Thunnissen E, Smit EF, de Langen AJ. Niemeijer AN, et al. J Nucl Med. 2022 Mar;63(3):362-367. doi: 10.2967/jnumed.121.261926. Epub 2021 Jul 16. J Nucl Med. 2022. PMID: 34272316 Free article.

10

¹⁸F-FDG maximum standard uptake value predicts PD-L1 expression on tumor cells or tumor-infiltrating immune cells in non-small cell lung cancer.

Hu B, Chen W, Zhang Y, Shi H, Cheng D, Xiu Y. Hu B, et al. Ann Nucl Med. 2020 May;34(5):322-328. doi: 10.1007/s12149-020-01451-0. Epub 2020 Mar 4. Ann Nucl Med. 2020. PMID: 32130663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year